ArticleHeliyon2023
Deep fusion of multi-modal features for brain tumor image segmentation.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- PF-CMNet: Progressive Frequency-Aware Cross-Modal Network with Missing-Modality Distillation for 3D Brain Tumor Segmentation.Brain sciences · 2026Article
- FMCL: a transformer-based feature-map classifier learning approach for enhanced brain tumor detection in MRI.Scientific reports · 2026Article
- Advanced finite segmentation model with hybrid classifier learning for high-precision brain tumor delineation in PET imaging.Scientific reports · 2025Article
- Multi-Modality Fusion and Tumor Sub-Component Relationship Ensemble Network for Brain Tumor Segmentation.Bioengineering (Basel, Switzerland) · 2025Article
- Implication of tumor morphology and MRI characteristics on the accuracy of automated versus human segmentation of GBM areas.Scientific reports · 2025Article
- Application of MRI image segmentation algorithm for brain tumors based on improved YOLO.Frontiers in neuroscience · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate segmentation of pathological regions in brain magnetic resonance images (MRI) is essential for the diagnosis and treatment of brain tumors. Multi-modality MRIs, which offer diverse feature information, are commonly utilized in brain tumor image segmentation. Deep neural networks have become prevalent in this field; however, many approaches simply concatenate different modalities and input them directly into the neural network for segmentation, disregarding the unique characteristics and complementarity of each modality. In this study, we propose a brain tumor image segmentation method that leverages deep residual learning with multi-modality image feature fusion. Our approach involves extracting and fusing distinct and complementary features from various modalities, fully exploiting the multi-modality information within a deep convolutional neural network to enhance the performance of brain tumor image segmentation. We evaluate the effectiveness of our proposed method using the BraTS2021 dataset and demonstrate that deep residual learning with multi-modality image feature fusion significantly improves segmentation accuracy. Our method achieves competitive segmentation results, with Dice values of 83.3, 89.07, and 91.44 for enhanced tumor, tumor core, and whole tumor, respectively. These findings highlight the potential of our method in improving brain tumor diagnosis and treatment through accurate segmentation of pathological regions in brain MRIs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.